WASHINGTON – Paul M. Karpecki, OD, FAAO, reported on new and up-and-coming ocular therapeutics at a continuing education session here at Optometry’s Meeting.
Allergan received FDA approval in April to market TrueTear intranasal tear neurostimulator.
This activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc.
Search Healio's robust listing of national and international medical meetings.
Tell us what you think about Healio.com »
©2017 Healio All Rights Reserved.